Shanghai United Imaging Healthcare Future Growth
Future criteria checks 4/6
Shanghai United Imaging Healthcare is forecast to grow earnings and revenue by 32.3% and 17.5% per annum respectively. EPS is expected to grow by 32.5% per annum. Return on equity is forecast to be 12.3% in 3 years.
Key information
32.3%
Earnings growth rate
32.5%
EPS growth rate
| Medical Equipment earnings growth | 26.4% |
| Revenue growth rate | 17.5% |
| Future return on equity | 12.3% |
| Analyst coverage | Good |
| Last updated | 13 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 17,518 | 3,137 | 1,897 | 2,533 | 15 |
| 12/31/2025 | 14,292 | 2,432 | 1,236 | 2,080 | 16 |
| 12/31/2024 | 11,006 | 1,633 | 2,420 | 2,404 | 10 |
| 9/30/2024 | 10,933 | 1,581 | -2,501 | -530 | N/A |
| 6/30/2024 | 11,473 | 1,987 | -1,599 | 19 | N/A |
| 3/31/2024 | 11,548 | 2,008 | -1,740 | -211 | N/A |
| 12/31/2023 | 11,411 | 1,974 | -943 | 133 | N/A |
| 9/30/2023 | 10,812 | 1,822 | -107 | 705 | N/A |
| 6/30/2023 | 10,337 | 1,820 | 124 | 952 | N/A |
| 3/31/2023 | 9,792 | 1,680 | 225 | 890 | N/A |
| 12/31/2022 | 9,238 | 1,656 | -59 | 683 | N/A |
| 9/30/2022 | 8,446 | 1,545 | -313 | 310 | N/A |
| 6/30/2022 | 8,341 | 1,544 | -110 | 435 | N/A |
| 3/31/2022 | 7,531 | 1,423 | -111 | 361 | N/A |
| 12/31/2021 | 7,254 | 1,417 | 596 | 942 | N/A |
| 12/31/2020 | 5,761 | 903 | 2,607 | 3,310 | N/A |
| 12/31/2019 | 2,979 | -74 | -391 | 258 | N/A |
| 12/31/2018 | 2,035 | -126 | -349 | 212 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688271's forecast earnings growth (32.3% per year) is above the savings rate (2.8%).
Earnings vs Market: 688271's earnings (32.3% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 688271's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688271's revenue (17.5% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 688271's revenue (17.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688271's Return on Equity is forecast to be low in 3 years time (12.3%).